Non-Controlling Interests in M&A Enterprise Value: How to Find, Value, and Record Them

The enterprise value bridge formula reads: equity value plus net debt plus preferred equity plus non-controlling interests. In most transactions, the non-controlling interest line is zero or immaterial, and analysts skip it without consequence. But when a target consolidates subsidiaries it does not fully own — a common structure in Asia-Pacific conglomerates, utility companies with joint ventures, or any company that grew through partial acquisitions — ignoring non-controlling interests understates enterprise value and makes the resulting EV/EBITDA multiple incomparable to transactions where the same component was included.

This article explains what a non-controlling interest is, why it belongs in the EV bridge, how to find the right value in public filings, and how to record it consistently across a precedent set.

What a non-controlling interest is

When Company A owns 70% of Subsidiary B, the remaining 30% is a non-controlling interest — the third-party claim on Subsidiary B’s net assets and earnings. Under both IFRS (IAS 27, IFRS 10) and US GAAP (ASC 810), Company A is required to consolidate 100% of Subsidiary B’s assets, liabilities, revenues, and earnings into its own financial statements. It does not consolidate a pro-rated 70%.

That full consolidation is what creates the NCI adjustment in the EV bridge. The parent’s consolidated income statement includes all of Subsidiary B’s EBITDA contribution. If you calculate an EV/EBITDA multiple using consolidated EBITDA — as you should, because that is the number disclosed in the target’s filings and in deal announcements — then EV must reflect the cost to acquire exposure to all of those earnings, not just the 70% the parent legally owned. The non-controlling interest line accounts for the remaining claim.

The terminology has shifted over time. Older filings and some current data providers label this component “minority interest.” Current IFRS and US GAAP use “non-controlling interest.” They describe the same economic reality.

Why NCI increases enterprise value

Enterprise value is meant to represent what it costs to own the entire operating enterprise, free of its financing structure. A buyer acquiring 100% of Company A is acquiring, through that purchase, indirect exposure to 100% of Subsidiary B’s operations — even though Company A only owned 70% of Subsidiary B. The consolidated EBITDA in the denominator already reflects 100%. The EV in the numerator must as well.

A worked example makes this concrete. Suppose:

Company A (the acquisition target) has consolidated EBITDA of $120 million.
Subsidiary B contributes $40 million of that total.
Company A owns 70% of Subsidiary B; the remaining 30% is owned by an external party.
Company A’s equity market value at announcement is $900 million.
Net debt (excluding NCI) is $100 million.
The book value of the NCI on Company A’s balance sheet is $60 million.

Enterprise value excluding NCI = $900M + $100M = $1,000M. Implied EV/EBITDA excluding NCI = $1,000M ÷ $120M = 8.3×.

Enterprise value including NCI = $900M + $100M + $60M = $1,060M. Implied EV/EBITDA including NCI = $1,060M ÷ $120M = 8.8×.

The difference is half a turn of EBITDA. For a transaction where EBITDA is $120 million, half a turn translates to $60 million of purchase price. If some transactions in your precedent set include NCI in EV and others do not, you are comparing incompatible multiples.

Book value versus fair value: the measurement question

The book value of NCI on a consolidated balance sheet is a historical, accounting-derived figure. It reflects the proportionate share of Subsidiary B’s net assets as recorded when Subsidiary B was consolidated, updated for subsequent earnings and dividends. This figure often diverges from what the NCI stake is actually worth today.

Fair value of NCI is what the third-party minority shareholders could receive for their interest in an arm’s-length transaction. Under ASC 805 (US GAAP, effective 2009), an acquirer must measure NCI at fair value at the acquisition date. Under IFRS 3 (revised 2008), an acquirer may choose between measuring NCI at fair value (the “full goodwill” method) or at the NCI’s proportionate share of the acquiree’s identifiable net assets. The difference primarily affects how goodwill is allocated, not the economic reality of the minority claim.

For a precedent transaction analysis, this distinction matters in one specific way: the EV figure in the announcement should, in principle, reflect the fair value of NCI at that date. But announcements often do not break out NCI from the total EV figure. When a deal announcement states that “the transaction values the company at an enterprise value of $X billion,” you cannot always determine from that sentence alone whether NCI has been included at fair value, at book value, or excluded entirely.

This is why the disclosure sources below matter.

Where NCI is disclosed in public filings

Target company’s consolidated balance sheet (Form 10-K, Form 20-F, or local-equivalent annual report). The NCI appears as a separate line in the equity section of the consolidated balance sheet, typically labeled “non-controlling interests” or, in older filings, “minority interests.” This gives you the book value of NCI at the most recent reporting date — the starting point for estimating how large the component is relative to the overall deal.

Deal announcement and press release. Some deal announcements itemize the components of enterprise value explicitly, using language such as: “The aggregate enterprise value of approximately $2.4 billion reflects the equity consideration of $1.9 billion, net debt of $0.4 billion, and minority interests of $0.1 billion.” When that itemization is present, use the stated NCI value and note the source. When it is absent, cross-reference the proxy statement.

Proxy statement (DEF 14A) or scheme document. The financial analysis section of the proxy — which contains the fairness opinion delivered by the target’s financial adviser — typically describes the enterprise value used in each valuation methodology. Footnotes will often specify whether NCI was included and at what value. For international transactions, the scheme implementation document or the independent expert’s report contains equivalent disclosures. This is the most reliable source for understanding how the deal parties themselves calculated EV.

Schedule 14D-9 (Solicitation/Recommendation Statement). For tender offers, the target’s solicitation/recommendation statement includes the target board’s financial analysis and often presents the EV/EBITDA multiple implied by the offer price, with footnotes on NCI treatment.

Form 8-K (merger agreement). The merger agreement filed as Exhibit 2.1 to Form 8-K may include a definition of “Company Enterprise Value” or “Aggregate Consideration” that specifies, in the legal definition, whether NCI is a component. Where the legal definition controls, use that value.

Deriving NCI value when the filing is not explicit

When the announcement does not itemize NCI and the proxy is not yet available:

For listed subsidiaries. If Subsidiary B is itself a publicly traded company, the NCI fair value is directly observable: number of minority shares outstanding × current share price. Use the closing price on the day before the deal announcement (the unaffected price) rather than the post-announcement price, because the announcement may have moved Subsidiary B’s share price. Record the number of minority shares, the reference date, and the share price used.

For unlisted subsidiaries. The book value from the most recent consolidated balance sheet is the only public figure available. Use it, flag that it is book value rather than fair value, and note the most recent balance-sheet date. Where book value is clearly stale or materially understated (for example, a subsidiary acquired years ago that has grown significantly), note the limitation in your documentation rather than substituting an estimated fair value not supported by public disclosure.

For consolidated joint ventures. Joint ventures proportionally consolidated (IAS 31, older GAAP) create a slightly different issue: the parent may already present only its proportionate share of revenue and EBITDA, in which case no NCI adjustment is needed for the joint venture. Confirm the consolidation method in the notes to the financial statements before applying an NCI add-back.

Partial acquisitions and minority stake transactions

When an acquirer buys less than 100% of a target — say, a 60% controlling stake in a public company — the transaction creates a new NCI at the parent level, but the mechanics for a precedent analysis are different.

The disclosed equity consideration typically covers the acquired portion only (60% of shares). The implied total equity value for the target is: disclosed equity consideration ÷ fraction acquired. Or equivalently, you can use the per-share consideration × total diluted shares outstanding, regardless of the fraction acquired. From there, the EV bridge applies normally.

A partial acquisition should be flagged explicitly in your precedent set because:

The buyer may have paid a control premium for 60% but not for the full entity, making the implied 100% equity value an extrapolation rather than a confirmed price.
The new NCI created at closing is a structural feature of the acquirer’s pro-forma balance sheet, not the target’s standalone EV.
Multiples from partial acquisitions reflect a different control context than multiples from 100% acquisitions, particularly in sectors where minority protections constrain operational flexibility.

If your precedent set includes partial acquisitions, separate them from full-control transactions or include a column clearly marking the stake acquired.

When NCI is material and when it can be disregarded

For most M&A targets, NCI is immaterial. A company that owns all its subsidiaries outright has no NCI line on its balance sheet, and the EV bridge collapses to equity value plus net debt plus preferred equity.

NCI becomes material — typically requiring explicit treatment — in several contexts:

Asian conglomerates and cross-holding structures. Listed company groups in Japan, South Korea, China, and Southeast Asia frequently hold partial stakes in numerous subsidiaries and affiliates. NCI balances can represent 10–20% of consolidated equity value in large groups.
Utility and infrastructure joint ventures. Power generators, pipeline operators, and port operators often hold 50–75% stakes in operating assets through joint ventures with government entities or co-investors.
Partial acquisition sequences. A company that acquired a series of controlling stakes without buying out minority shareholders accumulates NCI across multiple subsidiaries.
Listed subsidiaries. When a consolidated subsidiary has its own public float, the observable NCI value can be significant and is straightforward to calculate from market data.
Retail and franchise groups. Franchise network operators sometimes hold partial stakes in franchised outlets, particularly in international expansion structures.

A practical threshold: when the NCI balance on the most recent balance sheet exceeds 2–3% of the total disclosed enterprise value, include it explicitly and document how you valued it. Below that threshold, note that NCI was reviewed and determined to be immaterial.

Consistency requirements in a precedent set

The core discipline is the same as for every other component of the EV bridge: whatever you do for one transaction, do for all transactions.

A precedent set where some EV figures include NCI at fair value, some include it at book value, and some exclude it entirely produces incomparable multiples. The adjustment may seem small for any individual transaction, but the aggregate distortion can skew the range materially if the transactions with high NCI balances happen to cluster at the high or low end of the multiple distribution.

Before assembling a set that spans companies in sectors or geographies where NCI is common, decide your treatment policy:

Will you include NCI for all transactions where it exceeds the materiality threshold?
For listed subsidiary stakes, will you use the unaffected market price or the book value?
For unlisted subsidiaries, will you flag book-value NCI as an approximation?
How will you handle transactions where the NCI treatment in the deal announcement cannot be determined from public filings?

Document that policy at the top of the analysis. If a transaction’s NCI treatment cannot be verified from the proxy or other public source, state that the multiple is presented on the basis available from public disclosure and note the limitation.

What to record for each transaction

For every transaction in a precedent set where NCI is non-trivial, the documentation should capture:

the NCI balance from the most recent consolidated balance sheet prior to announcement, with the balance-sheet date;
whether the listed subsidiary prices or book value was used for fair value estimation, and why;
whether the deal announcement, proxy, or other filing explicitly stated the NCI component of EV, and if so, the stated value and source;
the resulting EV with NCI included and the multiple derived;
a flag for partial acquisitions noting the stake acquired and how the implied 100% equity value was calculated.

Non-controlling interests are a less common source of error than missed debt or a wrong financial period, but when they are present in a target’s structure they can shift an EV/EBITDA multiple by a meaningful fraction of a turn. PrivyLogic records enterprise value from disclosed transaction sources; where the NCI treatment is specified in public filings, that context is captured alongside the multiple. For assembling a comparable set with consistent NCI treatment across all transactions, see the available plans. For enterprise enquiries, contact the team.

Sources

IFRS 3 Business Combinations — Measurement of Non-Controlling Interests — IFRS Foundation; accessed September 18, 2026
ASC 805 Business Combinations — Recognition and Measurement Principles — Financial Accounting Standards Board (FASB); accessed September 18, 2026